Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting
Phase
N/A
Condition
Renal Failure
Kidney Disease
Kidney Failure (Pediatric)
Treatment
N/AClinical Study ID
TX264160
Ages 18-79 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Be aged 18 through 79 years of age
- Participants have not donated blood within 56 days of study entry or plasma within 7 days of study entry and must refrain from blood donation from study center admission, throughout the study period, and continuing for at least 30 days following the last dose of study drug
- Have renal impairment classification at screening that has been unchanged during the 3 months prior to screening
Exclusion
Exclusion Criteria:
Study Design
Study Start date:
January 26, 2021
Estimated Completion Date:
Study Description
Connect with a study center
Advanced Pharma - Miami
Miami, Florida 33147
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.